| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.53B | 66.30B | 60.78B | 55.46B | 51.42B | 49.68B |
| Gross Profit | 18.44B | 17.45B | 16.19B | 14.60B | 16.72B | 18.23B |
| EBITDA | 6.62B | 6.28B | 6.11B | 5.77B | 6.89B | 7.89B |
| Net Income | 1.59B | 1.73B | 796.00M | 942.00M | 2.28B | 4.17B |
Balance Sheet | ||||||
| Total Assets | 91.24B | 89.42B | 90.07B | 85.05B | 75.13B | 69.16B |
| Cash, Cash Equivalents and Short-Term Investments | 31.93B | 30.25B | 33.47B | 28.31B | 21.21B | 23.65B |
| Total Debt | 45.15B | 46.34B | 44.28B | 41.29B | 32.39B | 27.62B |
| Total Liabilities | 54.72B | 53.37B | 52.48B | 48.76B | 39.38B | 34.92B |
| Stockholders Equity | 35.10B | 34.64B | 35.77B | 34.64B | 34.18B | 32.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.72B | 3.21B | 685.00M | -5.08B | -2.65B |
| Operating Cash Flow | 0.00 | 4.21B | 5.94B | 3.37B | 3.35B | 5.61B |
| Investing Cash Flow | 0.00 | -10.76B | -2.25B | -7.42B | -9.59B | -3.62B |
| Financing Cash Flow | 0.00 | -251.00M | 2.25B | 6.85B | 3.55B | -2.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥20.04B | 9.88 | ― | 3.46% | 3.87% | 5.89% | |
76 Outperform | ¥525.19B | 11.76 | 8.51% | 2.25% | 3.33% | 9.57% | |
76 Outperform | ¥177.24B | 11.81 | ― | 4.91% | 6.35% | 14.05% | |
75 Outperform | ¥34.56B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥183.43B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
63 Neutral | ¥39.69B | 8.04 | ― | 1.90% | 6.70% | 53.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |